Heart transplantation in cardiac storage diseases: data on Fabry disease and cardiac amyloidosis
- 16 April 2020
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 25 (3) , 211-217
Abstract
Purpose of review: To deeply investigate one type of intracellular cardiac storage disease, the Fabry disease and one example of extracellular cardiac storage disease, the cardiac amyloidosis, with the aim to collect data about cardiac treatment at the end-stage level and the feasibility of heart transplantation (HTx) in this setting of patients. Recent findings: Some registry describes that Fabry disease and cardiac amyloidosis showed similar characteristics as hypertrophic cardiomyopathies; thus, their correct diagnosis is often missing or time consuming. A multiorgan approach is mandatory to recognize the main systemic findings of these diseases, involving also the kidneys, the brain, the autonomous system and the skin. Summary: The early diagnosis of these diseases is required to start as soon as possible the correct therapy for the patients affected. However, the end-stage heart failure is common and HTx could be offered to selected patients, especially if affected by light chain cardiac amyloidosis, to allow to perform the autologous stem cell transplantation after the cardiac transplant. Considering the Fabry disease patients, the enzyme recombinant therapy is also mandatory after HTx to avoid potential release of the systemic disease on the donor graft.Keywords
This publication has 54 references indexed in Scilit:
- Spectrum of Restrictive and Infiltrative CardiomyopathiesJACC, 2018
- Affairs of the heart: outcomes in men and women with hypertrophic cardiomyopathyEuropean Heart Journal, 2017
- Anderson-Fabry Disease and Other Lysosomal Storage DisordersCirculation, 2014
- Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal, 2012
- 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular PathologyCardiovascular Pathology, 2012
- Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular PathologyCardiovascular Pathology, 2012
- Infiltrative Cardiovascular DiseasesJACC, 2010
- Fabry's diseaseThe Lancet, 2008
- Prevalence of Lysosomal Storage DisordersJAMA, 1999
- Enzymatic Defect in Fabry's DiseaseNew England Journal of Medicine, 1967